150 related articles for article (PubMed ID: 16285736)
1. Upstream polybasic region in peptides enhances dual specificity for prenylation by both farnesyltransferase and geranylgeranyltransferase type I.
Hicks KA; Hartman HL; Fierke CA
Biochemistry; 2005 Nov; 44(46):15325-33. PubMed ID: 16285736
[TBL] [Abstract][Full Text] [Related]
2. Peptide specificity of protein prenyltransferases is determined mainly by reactivity rather than binding affinity.
Hartman HL; Hicks KA; Fierke CA
Biochemistry; 2005 Nov; 44(46):15314-24. PubMed ID: 16285735
[TBL] [Abstract][Full Text] [Related]
3. Lysine beta311 of protein geranylgeranyltransferase type I partially replaces magnesium.
Hartman HL; Bowers KE; Fierke CA
J Biol Chem; 2004 Jul; 279(29):30546-53. PubMed ID: 15131129
[TBL] [Abstract][Full Text] [Related]
4. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae.
Trueblood CE; Ohya Y; Rine J
Mol Cell Biol; 1993 Jul; 13(7):4260-75. PubMed ID: 8321228
[TBL] [Abstract][Full Text] [Related]
5. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.
James GL; Goldstein JL; Brown MS
J Biol Chem; 1995 Mar; 270(11):6221-6. PubMed ID: 7890759
[TBL] [Abstract][Full Text] [Related]
6. Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase.
Caplin BE; Ohya Y; Marshall MS
J Biol Chem; 1998 Apr; 273(16):9472-9. PubMed ID: 9545274
[TBL] [Abstract][Full Text] [Related]
7. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
Reid TS; Terry KL; Casey PJ; Beese LS
J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
[TBL] [Abstract][Full Text] [Related]
8. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
[TBL] [Abstract][Full Text] [Related]
9. The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.
GarcĂa-Torres D; Fierke CA
J Biol Chem; 2019 Aug; 294(31):11793-11804. PubMed ID: 31197034
[TBL] [Abstract][Full Text] [Related]
10. Sequence dependence of protein isoprenylation.
Moores SL; Schaber MD; Mosser SD; Rands E; O'Hara MB; Garsky VM; Marshall MS; Pompliano DL; Gibbs JB
J Biol Chem; 1991 Aug; 266(22):14603-10. PubMed ID: 1860864
[TBL] [Abstract][Full Text] [Related]
11. The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.
Long SB; Casey PJ; Beese LS
Structure; 2000 Feb; 8(2):209-22. PubMed ID: 10673434
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic.
Roskoski R; Ritchie PA
Biochemistry; 2001 Aug; 40(31):9329-35. PubMed ID: 11478901
[TBL] [Abstract][Full Text] [Related]
14. CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB.
Armstrong SA; Hannah VC; Goldstein JL; Brown MS
J Biol Chem; 1995 Apr; 270(14):7864-8. PubMed ID: 7713879
[TBL] [Abstract][Full Text] [Related]
15. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
Terry KL; Casey PJ; Beese LS
Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
[TBL] [Abstract][Full Text] [Related]
16. Targeted reengineering of protein geranylgeranyltransferase type I selectivity functionally implicates active-site residues in protein-substrate recognition.
Gangopadhyay SA; Losito EL; Hougland JL
Biochemistry; 2014 Jan; 53(2):434-46. PubMed ID: 24344934
[TBL] [Abstract][Full Text] [Related]
17. Efficient farnesylation of an extended C-terminal C(
Blanden MJ; Suazo KF; Hildebrandt ER; Hardgrove DS; Patel M; Saunders WP; Distefano MD; Schmidt WK; Hougland JL
J Biol Chem; 2018 Feb; 293(8):2770-2785. PubMed ID: 29282289
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions that convert the protein substrate specificity of farnesyltransferase to that of geranylgeranyltransferase type I.
Del Villar K; Mitsuzawa H; Yang W; Sattler I; Tamanoi F
J Biol Chem; 1997 Jan; 272(1):680-7. PubMed ID: 8995312
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
[TBL] [Abstract][Full Text] [Related]
20. Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release.
Furfine ES; Leban JJ; Landavazo A; Moomaw JF; Casey PJ
Biochemistry; 1995 May; 34(20):6857-62. PubMed ID: 7756316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]